Real world duration of curative intent breast, colorectal, non-small cell lung, and prostate cancer treatment

BackgroundAdvances in curative treatment for breast, colorectal, NSCLC and prostate cancer have led to improvements in cancer survival. Cancer treatment and recovery time can vary depending on the recommended modalities and intensity of therapy. Our objective was to determine the current real world...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC cancer 2021-03, Vol.21 (1), p.215-215, Article 215
Hauptverfasser:	Wong, Selina K., Hamm, Jeremy, Shokoohi, Aria, McGahan, Colleen E., Ho, Cheryl
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvant Age Breast Breast cancer Breast Neoplasms - therapy Cancer Cancer therapies Carcinoma, Non-Small-Cell Lung - therapy Care and treatment Chemotherapy Colorectal Colorectal cancer Colorectal Neoplasms - therapy Combined Modality Therapy Diagnosis Endocrine therapy Ethics Evaluation Female Humans Life Sciences & Biomedicine Lung cancer Lung Neoplasms - therapy Male Medical leave Middle Aged Neoplasm Staging Non-small cell lung carcinoma Oncology Oncology, Experimental Patients Prognosis Prostate cancer Prostatic Neoplasms - therapy Radiation therapy Retrospective Studies Science & Technology Small cell lung carcinoma Surgery Time Factors Treatment duration Workplace
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	BackgroundAdvances in curative treatment for breast, colorectal, NSCLC and prostate cancer have led to improvements in cancer survival. Cancer treatment and recovery time can vary depending on the recommended modalities and intensity of therapy. Our objective was to determine the current real world duration of curative treatments for the four common cancers.MethodsA retrospective review was completed of patients referred to BC Cancer from 2010 to 2016,
ISSN:	1471-2407 1471-2407
DOI:	10.1186/s12885-021-07923-4